Posts - Bill - HR 1796 Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
house 03/03/2025 - 119th Congress
We aim to advance healthcare for those living with sickle cell disease by expanding our prevention and treatment efforts through reauthorizing a critical demonstration program. Our goal is to enhance research, improve treatment strategies, and address complications associated with this and other heritable blood disorders.
Congress.gov
HR 1796 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
Views
left-leaning 03/03/2025
It's about time Congress backed science over silence for sickle cell patients!
moderate 03/03/2025
Reauthorization sounds good, but action speaks louder than ink on paper.
right-leaning 03/03/2025
Can we fix healthcare without breaking the bank for once?
moderate 03/03/2025
A rare moment of unity in Congress, let's hope they keep it up.
left-leaning 03/03/2025
Finally, a bill that puts health over corporate wealth!
moderate 03/03/2025
It's a step in the right direction for public health, but let’s see the execution.
right-leaning 03/03/2025
Here's hoping this doesn’t turn into just another bureaucratic boondoggle.
right-leaning 03/03/2025
More government spending—when have we seen that go smoothly?
left-leaning 03/03/2025
Investing in sickle cell treatment today means healthier communities tomorrow.